Quantitative liver function tests as surrogate markers for end-points in controlled clinical trials: A retrospective feasibility study

Hepatology

Volumn 26, Issue 6, 1997, Pages 1426-1433

  Lotterer, Erich ^a   Högel, Josef ^b   Gaus, Wilhelm ^b   Fleig, Wolfgang E ^a   Bircher, Johannes ^c  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b UNIVERSITY OF ULM   (Germany)

^c UNIVERSITY OF WITTEN HERDECKE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALCOHOL; ALKALINE PHOSPHATASE; AMINOPHENAZONE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GALACTOSE; GAMMA GLUTAMYLTRANSFERASE; IMMUNOGLOBULIN; PROTHROMBIN; SORBITOL;

ADULT; AGED; ALCOHOL ABSTINENCE; ALCOHOL BLOOD LEVEL; ALCOHOL LIVER CIRRHOSIS; ARTICLE; BREATH ANALYSIS; CLINICAL ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; LIVER CLEARANCE; LIVER FUNCTION TEST; LIVER METABOLISM; MALE; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; REPRODUCIBILITY;

EID: 0030698246     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510260609     Document Type: Article

References (19)

1. Tygstrup N, Juhl E. Dilemmas of controlled clinical trials in hepatology. In: Schaffner F, Sherlock S, Leevy CM, eds. The Liver and Its Diseases. Stuttgart, Thieme, 1974.
2. Villeneuve JP, Infante-Rivard C, Ampelas M, Pomier-Layrargues G, Huet PM, Marleau D. Prognostic value of the aminopyrine breath test in cirrhotic patients. HEPATOLOGY 1986;6:928-931.
3. Infante-Rivard C, Esnaola S, Villneuve JP. Clinical and statistical validity of conventional prognostic factors in predicting short-term survival among cirrhotics. HEPATOLOGY 1987;7:660-664.
4. Hay JE, Czaja AL, Rakela J, Ludwig J. The nature of unexplained chronic aminotransferase elevations of a mild to moderate degree in asymptomatic patients. HEPATOLOGY 1989;9:193-197.
5. Saunders JB, Walters JRF, Davies P, Paton A. A 20-year prospective study of cirrhosis. Br Med J 1981;282:263-266.
6. The Copenhagen study group for liver diseases. Testosterone treatment of men with alcoholic cirrhosis: a double-blind study. HEPATOLOGY 1986;6:807-813.
7. Orrego H, Blake JE, Blendis LM, Compton KV, Israel Y. Long-term treatment of alcoholic liver disease with propylthiouracil. N Engl J Med 1987;317:1421-1427.
8. Warnes TW, Smith A, Lee FI, Haboubi NY, Johnson PJ, Hunt L. A controlled trial of colchicine in primary biliary cirrhosis. Trial design and preliminary report. J Hepatol 1987;5:1-7.
9. Kershenobich D, Vargas F, Garcia-Tsao G, Tamayo RP, Gent M, Rojkind M. Colchicine in the treatment of cirrhosis of the liver. N Engl J Med 1988;318:1709-1713.
10. LaRusso NF, Wiesner RH, Ludwig J, MacCarty RL, Beaver SJ, Zinsmeister AR. Prospective trial of penicillamine in primary sclerosing cholangitis. Gastroenterology 1988;95:1036-1042.
11. Ferenci P, Dragosics B, Dittrich H, Frank H, Benda L, Lochs H, Meryn S, et al. Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver. J Hepatol 1989;9:105-113.
12. Mitchison HC, Palmer JM, Bassendine MF, Watson AJ, Record CO, James OFW. A controlled trial of prednisolone treatment in primary biliary cirrhosis. Three-year results. J Hepatol 1992;15:336-344.
13. Bunout D, Hirsch S, Petermann M, de la Maza MF, Silva G, Kelly M, Ugarte G, et al. Controlled study of the effect of silymarin on alcoholic liver disease. Rev Med Chil 1992;120:1370-1375.
14. A European multicentre study group. The results of a randomized double blind controlled trial evaluating malotilate in primary biliary cirrhosis. J Hepatol 1993;17:227-235.
15. Lombard M, Portmann B, Neuberger J, Williams R, Tygstrup N, Ranek L, Ring-Larsen H, et al. Cyclosporin: a treatment in primary biliary cirrhosis: results of a long-term placebo controlled trial. Gastroenterology 1993;104:519-526.
16. Hirsch S, Bunout D, de la Maza P, Iturriaga H, Petermann M, Icazar G, Gattas V, et al. Controlled trial on nutrition supplementation in outpatients with symptomatic alcoholic cirrhosis. J Parenter Enteral Nutr 1993;17:119-124.
17. Poupon RE, Poupon R, Balkau B, and the UDCA-PBC Study Group. Ursodiol for the long-term treatment of primary biliary cirrhosis. N Engl J Med 1994;330:1342-1347.
18. Knox TA, Kaplan MM. A double-blind controlled trial of oral-pulse methotrexate therapy in the treatment of primary sclerosing cholangitis. Gastroenterology 1994;106:494-499.
19. Heathcote EJ, Cauch-Dudek K, Walker V, Bailey RJ, Blendis LM, Ghent CN, Michieletti P, et al. The Canadian multicenter double-blind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis. HEPATOLOGY 1994;19:1149-1156.